Cullinan Therapeutics Inc (NAS:CGEM)
$ 23.49 0.71 (3.12%) Market Cap: 1.35 Bil Enterprise Value: 883.64 Mil PE Ratio: 0 PB Ratio: 2.31 GF Score: 36/100

Cullinan Oncology Inc at Stifel Targeted Oncology Days (Virtual) Transcript

Apr 26, 2023 / 06:30PM GMT
Release Date Price: $10.02 (-3.93%)
Brad Canino
Stifel Nicolaus - Stifel Financial Corp - Analyst

Okay. Thanks, everyone, for continuing to join us for the Stifel Targeted Oncology Days. My name's Brad Canino, a senior analyst here. I'm happy to continue the fireside chat sessions with Cullinan Oncology. With me, I've got Nadim Ahmed, the CEO. Thanks so much for joining us today.

Nadim Ahmed
Cullinan Oncology, Inc. - President & CEO

Great to be with you, Brad.

Questions & Answers

Brad Canino
Stifel Nicolaus - Stifel Financial Corp - Analyst

Now Nadim, can you start with an overview of Cullinan? Talk a little bit about your portfolio construction strategy as well; and the maturity of that portfolio now; and its clinical stage pipeline, of course, across the Phase 1 and pivotal-stage assets.

Nadim Ahmed
Cullinan Oncology, Inc. - President & CEO

Sure. Happy to do that, Brad. Let me start out talking a little bit about our strategic approach to drug discovery, which I think is quite

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot